✦ LIBER ✦

Intradermal Recombinant Hepatitis B Vaccine for Healthcare Workers Who Fail to Respond to Intramuscular Vaccine •

✍ Scribed by E. Geoffrey Playford, MBBS; Patrick G. Hogan, PhD; Amolak S. Bansal, DM; Kareena Harrison, BN; David Drummond, MBBS; David F. M. Looke, MBBS; Michael Whitby, MBBS

Book ID: 123996446
Publisher: University of Chicago Press
Year: 2002
Tongue: English
Weight: 119 KB
Volume: 23
Category: Article
ISSN: 0899-823X
DOI: 10.1086/502012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Higher‐Dose Intradermal He

Comparison of Higher‐Dose Intradermal Hepatitis B Vaccination to Standard Intramuscular Vaccination of Healthcare Workers •

✍ Elizabeth A. Henderson, PhD; Thomas J. Louie, MD, FRCPC; Karam Ramotar, PhD; Don 📂 Article 📅 2000 🏛 University of Chicago Press 🌐 English ⚖ 136 KB

Poor efficacy of intradermal administrat

Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine

✍ SD Shafran; LD Mashinter; A Lindemulder; GD Taylor; I Chiu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Clinical and immunologic features of chr

Clinical and immunologic features of chronic dialysis patients who fail to respond to hepatitis B vaccine

✍ Fredric G. Regenstein; Robert P. Perrillo; Carol Bodicky; Kira Stern; Steven Zel 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Susceptibility of healthcare workers in

Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake

✍ R.M. Suckling; M. Taegtmeyer; P.M. Nguku; S.S. Al-Abri; J. Kibaru; J.M. Chakaya; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Randomised placebo-controlled trial of r

Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccine

✍ P. Jungers; P. Devillier; H. Salomon; J.E. Cerisier; A.M. Courouce 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 305 KB

Phase I clinical study of a personalized

Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy

✍ Shigeru Yutani; Akira Yamada; Kazumi Yoshida; Yukari Takao; Mayumi Tamura; Nobuk 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 490 KB